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Loss of Periodontal Attachment in
HIV-Seropositive Military Personnel
Scott L. Tomar* Philip A. Swango* Dushanka V. Kleinman,' and Brian A. Burl
The cross-sectional relationship between severe loss of periodontal attachment
(LPA) and worsening immune status due to HIV infection was evaluated in 474 HIV-
infected subjects (416 men, 58 women) aged 18 to 49 years who had been classified
at stages 1 through 6 of the Walter Reed Army Institute of Research (WR) Staging
Classification System. LPA was measured at four sites per tooth using a manual probe;
severe LPA was defined as s 1 site/subject exhibiting 5: 5 mm LPA. Severe LPA
was found in 94 (20%) of the subjects. Modeling with multiple logistic regression
analysis revealed that WR stage and peripheral CD4+ lymphocyte cell counts were
not significant independent predictors of severe LPA. Severe LPA was more common
in subjects at WR stage 5 or 6 who exhibited oral candidiasis (OC), a marker of
immune system damage, than in persons at those WR stages without OC (odds ratio
= 7.85; 95% confidence interval (CI) = 1.94-31.81). After the analysis controlled for
WR stage, younger subjects receiving AZT had greater odds of severe LPA than same-
age subjects not taking the drug (e.g., odds ratio for subjects aged 30 years = 2.59;
95% CI = 1.22, 5.49). Other significant predictors in the model included male sex;
retired military status; cigarette smoking; and presence of cratered, ulcerated, or ne-
crotic interdental papillae. HIV-associated immune deficiency may be associated with
localized severe LPA, but this may be an indirect association due to medication use,
opportunistic infection, or other factors not captured by the WR staging system or
peripheral CD4+ cell counts. Comparison with the estimated prevalence of HIV-as-
sociated Periodontitis (HIV-P) in this population suggests that infected persons may
experience severe LPA that does not necessarily have the clinical presentation of HIV-
P. J Periodontol 1995;66:42I^428.
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A rapidly progressive form of destructive Periodontitis
among patients infected with human immunodeficiency
virus (HIV) was first observed at the University of Cali-
fornia, San Francisco, in the mid-1980s.1-2 This condition
has been termed HIV-associated Periodontitis, or HIV-P.3
Although HIV-P may be painful and may occasionally
result in rapid tooth loss,3 its prevalence has been low in
many HIV-seropositive study populations.4-6 Masouredis
et al.5 have proposed operational case definitions for HIV-
P that may be applied either with or without periodontal
probing. However, HIV-P may represent only one portion
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of the clinical spectrum of periodontal disease in HIV-
infected populations; more subtle destruction of peri-
odontal tissues may go undetected or be considered "nor-
mal" adult Periodontitis. Case definitions that address
only the more unusual clinical periodontal manifestations
may considerably underestimate the impact of HIV-as-
sociated immune deficiency on the periodontal health of
infected populations. Few published studies have used ob-
jectively measurable clinical indicators to try to quantify
the incidence or prevalence of periodontal destruction in
HIV-infected populations.47
This study had the following objectives: 1) estimate the
prevalence of severe LPA in an HIV-infected population;
2) compare the prevalence of severe LPA at various
stages of HIV disease; 3) identify behavioral, clinical, and
biological markers associated with increased odds of se-
vere LPA; 4) construct statistical models to help explain
the occurrence of severe LPA in HIV-infected individuals;
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Table 1. The Walter Reed Staging Classification for HIV Infection*
Chronic  Helper Delayed Opportunistic







WR 2 + + > 400 NL
WR 3 + +/- < 400 NL
WR 4 + +/- < 400  
WR 5 + +/- < 400 C or +
WR 6 + +/- <400 P/C +/- +
 Originally published in and reprinted with the permission of The New England Journal of Medicine; Redfield RR, Wright DC, Tramount EC. The
Walter Reed Staging Classification for HTLV-III/LAV infection; volume 314; pages 131-132; copyright 1986 Massachusetts Medical Society.




'Defined as 2 or more extrainguinal sites with lymph nodes al cm in diameter persistent for >3 months (+ = present,
-
= absent).
'Quantitative depletion (< 400 cells/mm3) must be present for at least 3 months for WR 3 classification.
•NL: normal DHS is defined as an intact cutaneous anergy, defined as an intact cutaneous response to only 1 of the 4 test antigens; C: complete
cutaneous anergy to the 4 test antigens.
"Clinical oral candidiasis including + KOH prep.
"Pneumocystis carinii pneumonia, CHS or disseminated toxoplasmosis, chronic cryptosporidiosis, candida esophagitis, disseminated histoplasmosis,
CNS or disseminated cryptococcosis, disseminated atypical mycobacterial disease, extrapulmonary tuberculosis, disseminated nocardiosis, disseminated
CMV, or chronic mucocutaneous herpes simplex.
and 5) compare the severe LPA attributable in the study
population to HIV-related damage to the immune system
to the estimated prevalence of HIV-P.
METHODS
Clinical Data
Since October 1985, all active-duty U.S. military person-
nel and applicants for recruitment have received manda-
tory blood testing for HIV antibody. Persons who tested
seropositive received medical evaluations and treatment
at regional medical care centers and were scheduled for
6-month follow-up. These persons were given the oppor-
tunity to participate in a medical research protocol, con-
ducted by the Walter Reed Army Institute of Research
(WR), on the natural history of HIV infection. Scientists
at the National Institute of Dental Research (NIDR) col-
laborated with Army investigators. NIDR's Oral Health
Research Activity began operating in 1989. Details of this
initiative were provided in an earlier report.8 The present
study was cross-sectional in design and used data col-
lected at baseline oral examinations conducted between
1989 and 1993.
Self-reported data were collected on demographic char-
acteristics, dental care utilization, oral symptoms, mouth
dryness and taste acuity, oral hygiene practices, and the
use of tobacco and alcohol. Study participants were clas-
sified for HIV disease progression according to the WR
Staging Classification System,9 which assigns subjects to
one of six progressive disease stages based on clinical
and laboratory presentations (Table 1). Staging of infected
persons ranges from stages WR 1 and 2, in which patients
are essentially asymptomatic with CD4+ T-lymphocyte
counts greater than 400 cells/mm3, to progressively more
advanced stages in which CD4+ T-lymphocyte counts are
below 400 cells/mm3 and clinical signs of damage to the
immune system appear.
Loss of periodontal attachment, measured by manual
probe at four sites per tooth as the distance in millimeters
from the cemento-enamel junction (CEJ) of a tooth to the
bottom of the gingival sulcus or pocket, was determined
for all teeth except third molars. LPA and gingival bleed-
ing were measured at disto-buccal, mid-buccal, mesio-
buccal, and mid-lingual sites. Plaque and calculus indi-
ces1011 were used to score the same four sites per tooth
on six teeth per subject (the four first molars and the
maxillary right and mandibular left central incisors). All
available interdental papillae anterior to the second mo-
lars were examined for signs of inflammation and destruc-
tion, for a maximum of 13 papillary units per arch (buccal
and lingual papillae were scored as one unit). Erythem-
atous gingival banding was assessed for all teeth except
third molars and all subjects were examined for lesions
on oral soft tissue. Oral examinations were conducted
through standardized examination protocol by a specialist
in oral medicine trained in the diagnosis of HIV-related
conditions and the use of oral epidemiological indices.
Currently, destructive Periodontitis has no universally
accepted operational definition, particularly for cross-sec-
tional investigations. Severe LPA was defined in this
study as the presence of one or more periodontal sites
with LPA s 5 mm. Referents were subjects whose most
severe LPA was < 5 mm.
The primary predictors considered in this study were
measures of immune system damage secondary to HIV
infection: WR stage of HIV disease (see Table 1) and
peripheral CD4+ lymphocyte counts taken at the time of
the oral examination. Other predictors and potential con-
founders included age and other demographic variables,
self-reported oral hygiene practices and utilization of den-
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tal care services, tobacco use, use of medications, clinical
measures of oral hygiene, and signs of pathology on peri-
odontal and oral soft tissue.
Because the association between age and cumulative
LPA was strong and the sample size and age distribution
precluded valid inferences on older persons, analysis was
restricted to subjects < 50 years of age.
Statistical Analysis
Statistical analysis for each outcome variable was per-
formed by using both bivariate contingency table analysis
and multiple logistic regression; estimated prevalence
odds ratios were the primary measures of association.
Crude bivariate analysis was performed for each predictor
and outcome variable, followed by age- and WR-stage-
stratified analysis to assess interaction and control for
confounding. Adjusted odds ratio estimates in the strati-
fied analyses were calculated by using the method of
Mantel and Haenszel.12 Guided by the results of bivariate
analyses, multiple logistic regression models were con-
structed to allow assessment of the independent effect of
the predictor variables by simultaneously controlling for
confounders and other correlates. Potential effect modi-
fication was assessed through the inclusion of interaction
terms. The statistical significance of main effect and in-
teraction terms in the logistic regression models was as-
sessed through the use of likelihood ratio tests.13 The
goodness-of-fit of the models was evaluated through the
use of the Hosmer-Lemeshow test procedure.13
The prevalence of HIV-P in the study population was
estimated by applying the criteria of Masouredis et al.5 to
measured clinical indicators (including periodontal prob-
ing) (Table 2). Although this case definition may have
been intended for application at the time of clinical ex-
amination, all applicable indicators had been individually
measured on participants in the present study, thereby al-
lowing a retrospective application of the case definition.
Among the cases of severe LPA observed in the study
population, the proportion that was attributable to pro-
found HIV-associated immune deficiency was assessed




where APT = the proportion of all cases of severe LPA
in the population attributable to profound immunodefi-
ciency, RR = the incidence rate ratio (estimated by the
prevalence odds ratio), and P, = the proportion of the
cases that had profound immunodeficiency.
The proportion of severe LPA cases attributable to pro-
found immune deficiency in this study population was
estimated by using the age-adjusted odds ratios associated
with peripheral CD4+ T-lymphocyte counts < 300 cells/
mm3. (Although low CD4+ T-lymphocyte counts did not
contribute significantly to the multivariate modeling of
severe LPA, it was a significant correlate in bivariate anal-
Table 2. Operational Definitions for a Diagnosis of HIV-Associated
Gingivitis (HIV-G) or HIV-Associated Periodontitis (HIV-P)*
I. Definitions requiring probing
HIV-G (must satisfy 1 and 2 plus either 3 or 4)
1. Bleeding on probing
2. Gingival index > 1 in at least 1 site
3. Presence of punctate or diffuse gingival erythema of the attached
gingiva
4. Red band of inflammation of the marginal gingiva
HIV-P (must satisfy 1 and 2 plus at least two of four characteristics
designated Al-A4)
1. Presence of HIV-G in at least one site
2. Attachment loss to pocket depth ratio of greater than 1.5 in any
one site.
Al. Patient complaint of bone pain
A2. Presence of exposed bone
A3. Presence of soft tissue or osseous necrosis
A4. Cratered papilla
 , Definitions not requiring probing
HIV-G (must satisfy 1 plus either 2 or 3)
1. Gingival index > 1 in at least 1 site
2. Presence of punctate or diffuse gingival erythema of the attached
gingiva
3. Red band of inflammation of the marginal gingiva
HIV-P (must satisfy 1 plus two of four characteristics designated Al-
A4)
1. Presence of HIV-G in at least one site
Al. Patient complaint of bone pain
A2. Presence of exposed bone
A3. Presence of soft tissue or osseous necrosis
A4. Cratered papilla
 Originally published in and reprinted with the permission of Journal
of the Acquired Immune Deficiency Syndrome; Masouredis CM, Katz
MH, Greenspan D, et al. Prevalence of HIV-associated Periodontitis and
gingivitis in HIV-infected patients attending an AIDS clinic; 1992;5:
479-483.
ysis and serves as a useful and valid marker for profound
immune system damage.15)
RESULTS
A total of 619 records were identified in the files of the
Oral Research Activity as of January 1993. Of these, 56
(9.0%) had no data on periodontal attachment loss and an
additional 64 records (10.3%) were missing data on HIV
disease staging or other important predictors. Twenty-two
(22) subjects (3.6%) were excluded because they were
over the age of 49 years, and 3 HIV-seronegative subjects
were omitted from analysis.
Characteristics of the remaining 474 study subjects are
presented in Table 3. Subjects missing periodontal data
tended to be older than subjects with complete periodon-
tal information (data not shown). Subjects not included
in analysis were more likely than included subjects to be
retired from military service rather than in active duty
and were more likely to have been at more advanced
stages of HIV disease. The two groups were similar on
most other demographic characteristics.
Overall, 94 (19.8%) study subjects had severe LPA.
Men were more likely than women to have severe LPA,
and subjects retired from military service were more like-
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*Data on country of birth are missing for 3 subjects.
ly to have experienced severe LPA than active duty per-
sonnel and dependents (Table 4). The odds of severe LPA
tended to increase with worsening severity of HIV dis-
ease. When the analysis controlled for age or WR stage,
subjects who first tested seropositive for HIV in 1988 or
later were significantly less likely to have severe LPA,
and duration of HIV infection was not significantly as-
sociated with severe LPA. Both current and former cig-
arette smokers were significantly more likely to have se-
vere LPA than nonsmokers. In all age groups, subjects
with plaque or calculus index scores above the group me-
dian were more likely to have severe LPA. Gingival
bleeding and severe LPA showed an effect modification
of age; subjects > 30 years of age who had higher mean
gingival bleeding index scores were less likely to have
severe LPA than same-aged subjects with lower bleeding
scores, although the stratum-specific odds ratio estimates
did not differ significantly from unity.
Severe LPA was significantly associated with the pres-
ence of a high number of erythematous interdental papil-
lae or one or more edematous or cratered papillae. Red
gingival banding showed no association with severe LPA.
The presence of one or more ulcerated or necrotic inter-
dental papillae was strongly associated with severe LPA,
but only seven subjects exhibited these conditions.
In every age group, subjects with oral candidiasis (OC),
defined as the presence of erythematous or pseudomem-
branous intraoral candidai infection, were more likely to
have severe LPA than subjects without OC. The strength
of association between OC and severe LPA increased with
advancing stage of HIV disease (Fig. 1). The odds ratio
estimates for stages WR 1 through 4 were not statistically
different from unity, although the Breslow-Day test for
homogeneity of the odds ratios (x2bd = 6.18, df = 2;  
= 0.046) indicated a probable effect modification of stage
of HIV disease on the association between OC and severe
LPA. Angular Cheilitis tended to be associated with in-
creased odds of severe LPA, although this condition was
observed in only 17 subjects. Subjects at stages WR 3 or
higher who had intraoral hairy leukoplakia, a lesion
strongly associated with immunosuppression and predic-
tive of AIDS,16 were more likely to exhibit severe LPA
than same-staged subjects without this lesion.
Subjects under 40 years of age who were taking AZT/
zidovudine were more likely to have severe LPA, al-
though this relation diminished with increasing age. Sub-
jects at stages WR 1 or WR 2 who were taking AZT/
zidovudine were twice as likely to have severe LPA as
subjects at these stages not taking these medications, al-
though the confidence intervals for the odds ratio esti-
mates included 1.0 in this stratified analysis. Small num-
bers of subjects in each cell prohibited a simultaneous
stratification on both age and WR stage for these vari-
ables.
In multiple logistic regression modeling, the strongest
correlate of severe LPA was age, which was controlled
for by its inclusion in multivariate models (Table 5). After
the analysis controlled for age, WR stage of disease, and
other variables in the model, men were about three times
as likely as women to have severe LPA, and retired sub-
jects were about twice as likely as active-duty subjects to
have severe LPA. WR stage of HIV disease was not a
significant independent correlate of severe LPA, but WR
stage of disease and the presence of oral candidiasis
strongly affected the likelihood of severe LPA. Multiple
logistic modeling indicated that subjects at WR stages 5
and 6 who had OC were over seven times more likely to
have severe LPA than subjects at those stages without
OC.
Nine subjects (1.9%) were classified as having HIV-P,
according to the case definition of Masouredis et al.5 An
estimated 16.6% (16 persons) of the severe LPA seen in
this study population was attributable to profound HIV-
associated immune deficiency (peripheral CD4+ T-lym-
phocyte counts < 300 cells/mm3) (Table 6).
discussion
Severe loss of periodontal attachment was not directly
associated with HIV-related immunosuppression after the
analysis controlled for other significantly associated vari-
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Table 4. Odds Ratio Estimates for Loss of Periodontal Attachment (LPA) a 5 mm Associated With
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ables. However, OC, which showed a considerable inter-
action with WR staging on the odds of severe LPA, was
itself strongly associated with advanced stages of HIV.
Given the cross-sectional nature of this study, few firm
conclusions may be reached. However, the data do sug-
gest that Candida species may be involved in the patho-
genesis of periodontal destruction in HIV-infected sub-
jects. This suggestion would be consistent with the find-
ings of Zambón and colleagues,6 who reported higher car-
riage rates of subgingival yeasts in subgingival plaques
in AIDS patients than in patients without AIDS. Alter-
natively, OC infection may be a marker for immune dis-
orders not measured in this study; mucocutaneous can-
didiasis in the presence of depressed CD4+ T-lymphocyte
counts has been considered a direct measure of immune
system damage.17 This interpretation would be consistent
with the relation between hairy leukoplakia, which is as-
sociated with immune deficiency,16 and severe LPA.
The significant association between AZT/zidovudine
use and severe LPA among younger subjects may indicate


















Walter Reed Stage of HIV
 No OCBOC
Figure 1. Prevalence of severe LPA (a 5 mm), by Walter Reed Stage
of HIV disease and presence of hairy leukoplakia or oral candidiasis.
the strong association between its use and the severity of
HIV disease. Yet AZT use was more strongly associated
with severe LPA than either of the two primary markers
of immunosuppression in this study. This finding may in-
dicate a possible pathogenic role for AZT in periodontal
destruction, perhaps through interference of neutrophil
Table 5. Odds Ratio Estimates for LPA a 5 mm Associated With
Selected Variables, Multiple Logistic Regression Modeling




















1 or more 12.32
Ulcerated gingival papillae
None* 1.00






WR Stage 1-2* 0.09
WR Stage 3-4* 1.49

















Odds ratio estimates in reference to same-aged subjects not taking AZT/
Zidovudine.
Odds ratio estimates in reference to same-staged subjects without oral
candidiasis.
Table 6. Association Between Peripheral CD4+ T-Lymphocyte
Counts and LPA a 5 mm and Proportion of Cases of LPA a 5 mm
Attributable to Peripheral CD4+ T-Lymphocyte Count < 300 Cells/
mm3
CD4+ < 300 cells/mm3
Yes No










Crude odds ratio (OR) = 1.82.
Age-adjusted odds ratio (ORadi) = 1.59.




= [0.59 X 0.451/1.59
= .166.
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function and induced neutropenia.1819 The neutrophil has
been characterized as the most important cell in host de-
fense against bacterial and certain fungal infections, and
abnormal neutrophil function is the major host factor im-
plicated in Periodontitis.20 The study design and the ab-
sence of data on neutrophil numbers or function in this
study do not permit a more detailed investigation of this
hypothesis. The interaction between AZT use and age on
the odds of severe LPA, with the strongest association
between AZT and LPA seen among younger subjects,
may indicate that the effects may be more noticeable at
an age where moderate to severe LPA is usually quite
rare, but may be difficult to separate from the lifetime
accumulation of LPA seen in older individuals. The avail-
able data did not allow us to assess potential confounding
of the association between AZT use and severe LPA due
to medical indicators of immune dysfunction; i.e., phy-
sicians may have prescribed AZT for conditions other
than depletion of CD4+ T-lymphocytes. AZT use was
also based on self-report by study participants and may
have been subject to misclassification, particularly if some
subjects were participants in blinded clinical protocols.
After other factors were controlled for, both current and
former smokers were more likely to have severe LPA than
those who had never smoked. This finding was consistent
with other epidemiological studies,2122 although the
pathogenic mechanism has not yet been elaborated.
Retirement status, which was associated with nearly
twice the odds of severe LPA, may reflect a possible self-
selection bias. "Retired" classification in this population
does not necessarily mean retirement after 20 years of
active duty; some subjects were medically retired as a
result of HIV-related disability, even though they had less
than 20 years of service. These subjects may have partic-
ipated in the study secondary to HIV-associated oral con-
ditions, including periodontal pathology. The finding may
also indicate that WR staging is not particularly sensitive
in describing the degree of morbidity, at least in terms of
factors involved in periodontal destruction.
The strong association between severe LPA and the
presence of interdental papillary cratering, ulcération or
necrosis, and erythema may indicate that those who ex-
perience one form of gingival inflammation or destruction
may be more likely to experience others as well. None of
these interdental papillary clinical signs were associated
with CD4+ T-lymphocyte count, WR staging, or AZT
use.
Although men may tend to have slightly more severe
LPA than women,23 it is difficult to explain the nearly
three-fold increase in the odds of severe LPA for males
in this study after the analysis controlled for age, HIV
disease stage, and other variables in the multivariate mod-
els. When the analysis controlled for mean plaque index
score (which did not contribute significantly in multivar-
: iate modeling) to assess whether the gender discrepancy
could be due to differences in oral hygiene, the OR es-
timate was only slightly attenuated. Perhaps HIV-disease-
related periodontal manifestations differ between the sex-
es, or the discrepancy may simply reflect the composition
of this particular study population.
The findings of this study are generally consistent with
other reports. In a 20-month longitudinal study of relative
attachment loss (RAL) in HIV-seropositive and HIV-se-
ronegative men, Barr and colleagues24 found that low
CD4+ T-lymphocyte counts were associated with in-
creased likelihood of RAL in subjects aged 35 years and
older. Friedman et al.25 found that AIDS patients in a clin-
ic for infectious disease had slightly higher mean attach-
ment loss than HIV-seropositive patients who did not
have AIDS, although small numbers of subjects resulted
in relatively imprecise estimates and an absence of statis-
tical significance.
The application of the case definition for HIV-P re-
sulted in nine subjects being classified as "diseased." The
study's relatively limited definition of profound immune
system damage secondary to HIV infection indicated
that about 16 of the 94 cases of severe LPA in this study
population were attributable to advanced immune defi-
ciency. This number is probably an underestimate, since
it does not include other HIV-associated factors that were
significantly associated with severe LPA (such as the
presence of OC), and since it uses odds ratio estimates
based on an exposure classification that characterizes
many of the HIV-infected individuals as "unexposed" (no
true control group is used). Although the calculation of
the attributable proportion used a simplistic definition of
exposure, it illustrates that HIV-P may represent only a
portion of the clinical spectrum of HIV-associated peri-
odontal destruction. Case definitions that are restricted to
the more severe periodontal manifestations may consid-
erably underestimate the impact of HIV infection on the
periodontal health of infected populations.
Bias may have been introduced by excluding subjects
who had missing periodontal data. Although the study
could not definitively explain the absence of periodontal
data for 56 subjects, notes in a number of records indi-
cated that the periodontal probings were not performed
because of either extremely painful periodontal tissues,
excessive bleeding that made probing measurements im-
possible, or systemic morbidity that resulted in a curtailed
oral examination. In addition, subjects excluded from
analysis were more likely to be retired from military ser-
vice, and tended to be at more advanced stages of HIV
disease than those included in analysis. The inclusion of
these subjects would likely have strengthened the asso-
ciation between markers of HIV-associated immune sys-
tem damage and severe LPA.
Although the cross-sectional design of this study pre-
cludes firm conclusions, the current investigation suggests
that HIV-associated immune deficiency may be associated
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with severe LPA that does not necessarily present as the
HIV-associated Periodontitis described by other research-
ers.2 Some of the "conventional Periodontitis" observed
in HIV-infected populations5 may be part of the clinical
spectrum of HIV-associated periodontal disease. Neither
the WR Staging Classification System nor peripheral
CD4+ T-lymphocyte counts may be adequate markers for
the immune system changes involved in the pathogenesis
of periodontal destruction in HIV-infected persons.
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